Biocon explores investment in Malaysia Bangalore, 24 January Biocon Limited, the country's second largest biotechnology firm has signed a Memorandum of Understadning (MoU) with Malaysia's Biotechnology Corporation (BiotechCorp) to explore collaboration and potential investment in Malaysia's biotechnology industy.
Biocon is in talks with Biotechcorp to manufacture biopharmaceutical products and formulation, within Malaysia's Nusajaya, Iskandar Malaysia, in the biotech park called the Bio-XCell Ecosystem.Biocon is also developing biotechnology infrastructure in the Bio-XCell Ecosystem Project. BiotechCorp is the lead development agency for the biotech industry in Malaysia and acts as a central contact point providing support, facilitation and advisory services for biotech and life sciences companies in Malaysia.
Kiran Mazumdar-Shaw, chairman and managing director, Biocon said, "The company is keen to explore Malaysia as a destination for our expansion. Malaysia and the Bio-XCell Ecosystem in Iskandar Malaysia are attractive propositions."